Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series C financing for Transcend Medical raises $22.5mm

Executive Summary

Ophthalmic surgical device maker Transcend Medical Inc. grossed $22.5mm in its Series C financing from 15 first-time and returning backers including an undisclosed global biopharma/device company. Transcend will spend the money on completing the US COMPASS trial of its CyPass Micro-Stent, a micro-invasive device for glaucoma patients implanted during cataract surgery, that reduces intra-ocular pressure.
Deal Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies